Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Cancer Science|June 3, 2009
Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosisKosuke Yoshihara, Atsushi Tajima, Dai Komata, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 28, 2005
[A dose escalation study of concurrent chemoradiation therapy with nedaplatin for cervical cancer]Masayuki Hatae, Takeshi Takahashi, Shoji Kodama, et al.The Journal of Clinical Investigation|August 16, 2013
Predicting time to ovarian carcinoma recurrence using protein markersJi-Yeon Yang, Kosuke Yoshihara, Kenichi Tanaka, et al.Plos One|March 20, 2010
Gene expression profile for predicting survival in advanced-stage serous ovarian cancer across two independent datasetsKosuke Yoshihara, Atsushi Tajima, Tetsuro Yahata, et al.Japanese Journal of Clinical Oncology|October 18, 2008
Phase II clinical trial of pegylated liposomal doxorubicin (JNS002) in Japanese patients with mullerian carcinoma (epithelial ovarian carcinoma, primary carcinoma of fallopian tube, peritoneal carcinoma) having a therapeutic history of platinum-based chemotherapy: a Phase II Study of the Japanese Gynecologic Oncology GroupNoriyuki Katsumata, Yasuhiro Fujiwara, Toshiharu Kamura, et al.Gynecologic Oncology|December 13, 2005
Mutational analysis of TP53 and p21 in familial and sporadic ovarian cancer in JapanTakayuki Amikura, Masayuki Sekine, Yasuo Hirai, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selectionToyomi Satoh, Masayuki Hatae, Yoh Watanabe, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young womenKimio Ushijima, Hideaki Yahata, Hiroyuki Yoshikawa, et al.European Journal of Cancer (Oxford, England : 1990)|January 7, 2015
Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumourToyomi Satoh, Yoichi Aoki, Takahiro Kasamatsu, et al.Reproductive Medicine and Biology|January 27, 2018
Measurement of endometrial thickness in premenopausal women in office gynecologyHiroshi Tsuda, Yoichi M Ito, Yukiharu Todo, et al.Pageof 4